Vernal Biosciences, Inc.

Amendment

CIK: 0001861147·Biotechnology·DELAWARE·Filed: Jun 16, 2023

Total Offering

$40,998,390

Amount Sold

$40,998,390

Investors

10

First Sale

May 10, 2022

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2020
Non-Accredited Investors: No

Related Persons

Name	Role
Christian Cobaugh	Related Person
David Anderson	Related Person
Daniella Kranjac	Related Person

Company

Vernal Biosciences, Inc.

261 Mountain View Drive

Colchester, VT, 05461

512-791-9680

SEC Filing

0001861147-23-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.